...Lilly and Leverkusen, Germany-based Bayer weren’t immediately able to comment. Schering-Plough Corp., of Kenilworth, N.J., and GlaxoSmithKline Plc, of London, help market Levitra in the U.S. Viagra, Cialis and Levitra work by relaxing muscles in blood vessels,...

...shortages would not affect pediatric versions of the vaccine. The Centers for Disease Control and Prevention said Merck competitor GlaxoSmithKline P.L.C. was producing enough hepatitis B vaccine to compensate for shortfalls. Merck spokeswoman Amy Rose said...

...diseases. Nitin Shah, consultant, PD Hinduja Hospital, said that in the next six to twelve months, British pharmaceutical giant GlaxoSmithKline (GSK) will introduce its hexa-vaccine in the country. So will Sanofi Pasteur, the vaccines arm of French multinational...

...response rates in the sector. In the past two years the company has helped brands including AstraZeneca, Roche Pharmaceuticals, GlaxoSmithKline, Merck and Bayer deepen their engagement with patients and physicians. Recently Kyp Systems launched a new Web...

...benefits of existing drugs. XenoPort is developing its lead product candidate in partnership with Astellas Pharma Inc. and GlaxoSmithKline. XenoPort's product candidates are being studied for the potential treatment of restless legs syndrome, neuropathic...

...Delhi: The Supreme Court today dismissed a petition by drug major GlaxoSmithKline Pharmaceuticals Ltd seeking to restrain the Centre from taking coercive action against the firm, on which the Union government slapped a notice to pay more than Rs3.18 crore. The...

...NEW DELHI: The Supreme Court on Tuesday dismissed a petition by drug major GlaxoSmithKline Pharmaceuticals Ltd (GSK) seeking to restrain the government from taking coercive action against the drug maker that has been asked to pay more than Rs 3.18 crore for...

... Anacor Pharmaceuticals, Inc. Raises $50 Million in Equity Financing from GlaxoSmithKline (GSK), Schering Corporation and Existing Investors 1/6/2009 PALO ALTO, Calif., Jan. 6 /PRNewswire/ -- Anacor Pharmaceuticals today announced...

...of compounds to treat inflammatory disease linked to the phospholipid pathways. Amira has a strategic partnership with GlaxoSmithKline for the development of FLAP (5-lipoxygenase activating protein) inhibitors in respiratory and cardiovascular disease. Amira...

...Palo Alto company plans to use the funding to further develop its product pipeline. The investment by GlaxoSmithKline and Schering Corp. fulfill the two companies’ investment obligations from ongoing collaborations with Anacor. After the funding the two companies’...